Process evaluation of a pharmacist‐led intervention aimed at deprescribing and appropriate use of cardiometabolic medication among adult people with type 2 diabetes

Abstract

AbstractBackgroundA quasi‐experimental study investigated a pharmacist‐led intervention aimed at deprescribing and medication management among adult patients with type 2 diabetes at risk of hypoglycaemia.ObjectiveThis study aimed to evaluate the process of implementing the intervention consisting of a tailored clinical medication review (CMR) supported by a training and a toolbox.MethodsMixed‐methods study based on the Grant framework, including the domains “recruitment,” “delivery of intervention” and “response” of pharmacists and patients. Data collected were administrative logs, semi‐structured observations of patient consultations (n = 8), interviews with pharmacists (n = 16) and patient‐reported experience measure (PREM) questionnaires (n = 66).ResultsTailored CMRs were conducted largely as intended for 90 patients from 14 pharmacies. Although patient selection based on a medication‐derived hypoglycaemia risk score was considered useful, pharmacists experienced barriers to proposing deprescribing in patients with recent medication changes, without current hypoglycaemic events, or treated by medical specialists. The training and toolbox were evaluated positively by the pharmacists. Overall, patients were satisfied with the CMR.ConclusionPharmacists and patients valued the CMR focusing on deprescribing and medication management. To optimize implementation and effectiveness of the intervention, improvements can be made to the patient selection, pharmacist training and the collaboration between healthcare professionals.